surmount-1 tirzepatide trial obesity without diabetes for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Tirzepatide for maintenance of bodyweight
Description
JHEP Rep 1 , 188198 (2019)
00656-2/asset/38c98550-9ec2-44e8-ba6a-dbb815075666/main.assets/gr1_lrg.jpg)
Clinical trials show great weight reduction
These studies consistently demonstrated superior glycemic control compared to placebo and active comparators, including established GLP-1 receptor agonists and insulin therapies
Am I a Good Candidate
00377-2/asset/5849e908-c26a-472e-b460-1c99904b95c5/main.assets/gr2.jpg)
K., Koo Y
